SS
BLUE

SBI Securities’s bluebird bio BLUE Stock Holding History

SBI Securities’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-171
Closed -$834 – 4152
2025
Q1 		$834 Sell
171
-34
-17% -$204 ﹤0.01% 2657
2024
Q4 		$1.71K Buy
+205
New +$1.79K ﹤0.01% 2369

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SBI Securities's BLUE Position: Q2 2025 in Review

SBI Securities sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 171 shares — an estimated $834 sold.

SBI Securities first reported a position in BLUE in Q4 2024 and held it in 2 quarters. The position peaked at $1.71K in Q4 2024. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • SBI Securities reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • SBI Securities sold 171 bluebird bio shares in Q2 2025, an estimated $834.
  • SBI Securities first reported a position in bluebird bio in Q4 2024 and held it in 2 quarters.
  • SBI Securities's bluebird bio position peaked at $1.71K in Q4 2024.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on SBI Securities's 13F filing for Q2 2025, filed 8 Aug 2025.